Share Name Share Symbol Market Type Share ISIN Share Description
Proteome Sciences Plc LSE:PRM London Ordinary Share GB0003104196 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 3.90 3.60 4.48 6,065 10:03:44
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 4.7 -0.0 0.1 78.0 11

Proteome Sciences PLC Director/PDMR Shareholding

02/07/2020 4:08pm

UK Regulatory (RNS & others)

Proteome Sciences (LSE:PRM)
Historical Stock Chart

From Apr 2020 to Oct 2020

Click Here for more Proteome Sciences Charts.


RNS Number : 9043R

Proteome Sciences PLC

02 July 2020

2 July 2020

Proteome Sciences plc

("Proteome Sciences" or the "Company")

Director/PDMR Shareholding

The Company has received notification from Vulpes Life Sciences Fund ("Vulpes") that on 30 June and 1 July 2020 it purchased 100,000 and 60,000 Ordinary Shares of 1p, respectively, in the capital of the Company ("Ordinary Shares") at an average price of 3.95p per Ordinary Share (the "Purchase"). Following the Purchase, Vulpes has a total direct and indirect interest in 65,363,158 Ordinary Shares, equivalent to 22.14% of Proteome Sciences' total issued share capital.

The Company would also like to announce that by virtue of Martin Diggle being a Director of both Vulpes Investment Management and the Company, he now has an interest in 65,363,158 Ordinary Shares of the Company representing 22.14% of the issued share capital of the Company.

The below notification is made in accordance with the requirements of the EU Market Abuse regulation.

 1.   Details of the person discharging managerial responsibilities/person 
       closely associated 
 a)   Name:                                      Martin Diggle 
     -----------------------------------------  -------------------------------- 
      Reason for the notification 
 a)   Position/status:                           Non-Executive Director 
     -----------------------------------------  -------------------------------- 
 b)   Initial notification/Amendment:            Initial Notification 
     -----------------------------------------  -------------------------------- 
      Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name:                                      Proteome Sciences Plc 
     -----------------------------------------  -------------------------------- 
 b)   LEI:                                       213800Q62ICXANKU2986 
     -----------------------------------------  -------------------------------- 
      Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions 
       have been conducted 
 a)   Description of the financial instrument,   Ordinary Shares of 1p nominal 
       type of instrument:                        value 
       Identification code:                       GB0003104196 
     -----------------------------------------  -------------------------------- 
 b)   Nature of the transaction:                 Purchase of Ordinary Shares 
     -----------------------------------------  -------------------------------- 
 c)   Price(s) and volume(s):                      Price(s)   Volume(s) 
                                                    4.00p      100,000 
                                                    3.90p      60,000 
     -----------------------------------------  -------------------------------- 
 d)   Aggregated information:                    Single transaction as in 
        *    Aggregated volume:                   4 c) above Average   Volume(s) 
                                                   3.95p     160,000 
        *    Price:                                         ---------- 
     -----------------------------------------  -------------------------------- 
 e)   Date of the transaction:                   30 June and 1 July 2020 
     -----------------------------------------  -------------------------------- 
 f)   Place of the transaction:                  London Stock Exchange, 
                                                  AIM (XLON) 
     -----------------------------------------  -------------------------------- 

For further information:

 Proteome Sciences plc 
 Dr Ian Pike, Interim Chief Executive   Tel: +44 (0)20 7043 2116 
  Officer/ Chief Scientific Officer 
 Richard Dennis, Chief Commercial 
 Allenby Capital Limited (Nominated Adviser & Broker) 
 John Depasquale / Jeremy Porter        Tel: +44 (0) 20 3328 5656 

About Proteome Sciences plc. ( )

Proteome Sciences plc is a specialist provider of contract proteomics services to enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. SysQuant(R) and TMT(R)MS2 are unbiased methods for identifying and contextualising new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator(TM) provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. Targeted assay development using mass spectrometry delivers high sensitivity, interference-free biomarker analyses in situations where standard ELISA assays are not available.

The Company has its headquarters in London, UK, with laboratory facilities in Frankfurt, Germany.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

July 02, 2020 11:08 ET (15:08 GMT)

1 Year Proteome Sciences Chart

1 Year Proteome Sciences Chart

1 Month Proteome Sciences Chart

1 Month Proteome Sciences Chart
ADVFN Advertorial
Your Recent History
Proteome S..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201021 10:40:52